1. Home
  2. ANET vs JNJ Comparison

ANET vs JNJ Comparison

Compare ANET & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Arista Networks Inc.

ANET

Arista Networks Inc.

HOLD

Current Price

$163.24

Market Cap

178.5B

ML Signal

HOLD

Logo Johnson & Johnson

JNJ

Johnson & Johnson

HOLD

Current Price

$240.87

Market Cap

542.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANET
JNJ
Founded
2004
1886
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.5B
542.4B
IPO Year
2014
2003

Fundamental Metrics

Financial Performance
Metric
ANET
JNJ
Price
$163.24
$240.87
Analyst Decision
Strong Buy
Buy
Analyst Count
17
20
Target Price
$175.18
$238.20
AVG Volume (30 Days)
8.2M
6.3M
Earning Date
05-05-2026
04-14-2026
Dividend Yield
N/A
2.36%
EPS Growth
23.32
90.50
EPS
0.80
2.14
Revenue
$9,005,700,000.00
N/A
Revenue This Year
$29.10
$6.63
Revenue Next Year
$21.80
$7.43
P/E Ratio
$195.64
$111.50
Revenue Growth
28.60
N/A
52 Week Low
$85.78
$149.04
52 Week High
$179.80
$251.71

Technical Indicators

Market Signals
Indicator
ANET
JNJ
Relative Strength Index (RSI) 55.59 65.80
Support Level $162.25 $233.83
Resistance Level $163.81 $246.40
Average True Range (ATR) 7.62 4.24
MACD -0.27 1.60
Stochastic Oscillator 56.69 94.32

Price Performance

Historical Comparison
ANET
JNJ

About ANET Arista Networks Inc.

Arista Networks is a networking equipment provider that primarily sells Ethernet switches and software to data centers. Its marquee product is its extensible operating system, or EOS, that runs a single image across every single one of its devices. The firm operates as one reportable segment. It has steadily gained market share since its founding in 2004, with a focus on high-speed applications. Arista counts Microsoft and Meta Platforms as its largest customers and derives roughly three quarters of its sales from North America.

About JNJ Johnson & Johnson

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.

Share on Social Networks: